IBKR Options Traders Turn Defensive as Sell-Off Extends
Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish
Interactive Brokers Group has now shed nearly 11% over the past month to $76.90, with options traders the most defensive they have been in a year.
The clearest signal right now is in the options market. The put/call ratio hit 0.87 on October 30, more than two standard deviations above its 20-day average of 0.78. That reading is the highest of the past year, with only the 52-week high of 0.93 standing above it. The jump came on the same day the stock fell nearly 6%, the sharpest single-session decline of recent weeks. A ratio this elevated reflects heavier-than-usual demand for downside protection relative to bullish positioning, a posture that has hardened as the price has continued to fall.
Short positioning, by contrast, is not the story here. Short interest is modest at about 2.9% of free float, and the past week actually saw shorts trim their exposure by 3.6%, even as the stock continued lower. Borrow remains trivially cheap at 0.27%, and share availability is essentially unlimited with 336 million shares accessible in the lending pool, many times larger than the short position. There is no meaningful borrow squeeze pressure. The selling this week has come from existing holders, not from a build in bearish structured positions. The one noteworthy lending market development over the past month is that short interest did grow about 25% in total between late September and mid-October, before partially unwinding this week.
On the buy side, a director made the week's most concrete statement. Lawrence Harris sold $2.1 million of stock on October 28 at $82.61, an open-market sale with no 10b5-1 plan attached. That is the largest insider transaction in the past 90 days, and on a discretionary basis it carries more interpretive weight than the small scheduled purchases made by a separate director under an automated plan throughout the same period. Net insider activity over the 90 days is a net sale of roughly $2.1 million in value terms.
The Street has not followed the stock lower in terms of conviction. Most analysts who updated their views this month kept positive ratings: Barclays reiterated Overweight and lifted its target to $117, while Evercore ISI initiated with Outperform and a $100 target in mid-October. BMO Capital trimmed its target to $100 from $105 while staying at Outperform. The consensus mean target is around $104.66, roughly 36% above where the stock is trading now. That gap reflects how far and fast the price has moved rather than any fresh wave of analyst downgrades. The EPS momentum score of 89 on the 30-day measure and 80 on the 90-day reading place IBKR near the top of its sector on earnings trajectory. The trailing P/E has compressed to about 25.4 times, down from above 27 a month ago. Peer performance on the week was broadly weak: HOOD fell more than 10%, COIN dropped over 12%, and GS and MS both closed down 3% or more on the day, so IBKR's 4.2% weekly decline is neither an outlier nor a comfort.
The next earnings event is scheduled for January 19, 2027. Between now and then, the put/call ratio and the pace of short interest rebuilding are the data points most worth tracking.
Stocks in this article
See the live data behind this article on ORTEX.
Open IBKR on ORTEX →How this article was generated
- Generated
- 31 Oct 2026, 20:38
- Data as of
- 31 Oct 2026, 20:37
- Prompt version
- v1.0
- Data sources
- Short interestCost to borrowUtilizationOptions flowEarningsAnalyst consensusInstitutional positioningORTEX Alpha signalsRecent ORTEX notesPrevious Mi Articles
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.